retatrutide clinical trial results trials weight loss New Phase 3 data just dropped 👀 Eli Lilly's retatrutide drug retatrutide clinical trials

The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide

Approximately 900 adult participants were enrolled across six randomized, double-blind, placebo-controlled clinical trials conducted between 2001 and 2006

(21) Participants had an average age of 63 (SD: 5.5, range 40-85 years) and an average BMI of 27.5 (SD: 4.5), consisting of 55 postmenopausal women and 9 men

The reality check and its a big one: as one set of doctors put it bluntly, unless youre a rat, you probably cant extrapolate this data (peptide expert discussion)